MedPath

Health Effects of Occupational Exposure to Combustion Particles - a Study on Volunteers Performing as Train Conductors

Not Applicable
Completed
Conditions
Cardiovascular Function
Genotoxicity
Interventions
Other: Electric train
Other: Diesel train
Registration Number
NCT03104387
Lead Sponsor
University of Copenhagen
Brief Summary

Ambient air pollution is a complex mixture of gaseous pollutants and particulate matter (PM). PM has a recognized important role in human health. There is a strong scientific consensus on the independent association of PM and adverse cardiovascular and respiratory effects, as well as cancer. It is reasonable to expect that the smaller particles (ultrafine particles, UFP) may have an enhanced toxicity relative to other PM size fractions, due to physical properties and potential to translocation beyond the lung.

A recent Danish report concluded that train conductors on a working day, and in two specific diesel engine trains, are exposed to higher concentrations of diesel exhaust than by constant stay in a busy street. Indeed, the average exposure for train conductors on such engines was around 100,000-150,000 UFP per cm3 as compared with around 40,000 per cm3 on a busy street in Copenhagen \[1\]. The aim of this study is to investigate if this occupational exposure is associated with vascular and respiratory impairment and DNA damage.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
29
Inclusion Criteria
  • Healthy volunteers
  • Legally competent subjects
Exclusion Criteria
  • Current smokers
  • Pregnancy
  • Alcohol and drug abuse
  • Prescriptionary use of anti-inflammatory or cardiovascular medication

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Electric train - low exposure scenarioElectric trainThe same study person will be exposed to two different scenarios, at different times and for three consecutive days. It will be a lag time of 2 weeks between each exposure scenario. The "low exposure" scenario is defined as a workday (6 hours) on the electric train. The Diesel Train Scenario is performed twice. After the scenario completion (on the third day in defined train routes) the vascular function, lung function, blood and urine samplings are performed.
Diesel train - exposure scenarioDiesel trainThe same study person will be exposed to two different scenarios, at different times and for three consecutive days. It will be a lag time of 2 weeks between each exposure scenario. The "exposure" scenario is defined as a workday (6 hours) on the diesel ME-driven model regional train. The Diesel Train Scenario is performed twice. After the scenario completion (on the third day in defined train routes) the vascular function, lung function, blood and urine samplings are performed.
Primary Outcome Measures
NameTimeMethod
DNA damage in peripheral blood mononuclear cellsBlood is sampled, prepared and stored after each exposure scenario (on the third day after 6 hours on defined train routes per day). Analysis is performed after sample collection completion.

The levels of strand breaks and formamidopyrimidine-DNA-glycosylase (FPG) sites are measured with the single cell gel electrophoresis assay (comet assay) \[7-13\]

Reactive hyperemia index measured by peripheral arterial tonometryPeripheral arterial tonometry is assessed after each exposure scenario (on the third day after 6 hours on defined train routes per day)

The primary outcome will be measured in the form of post-ischemic variation followed by the measurement of the vasomotor function after the administration of nitroglycerin, to allow the investigation of the endothelium independent vasodilatation. The portable device EndoPAT 2000 will be used (Itamar Medical Ltd, Israel) \[2-6\].

Heart rate variabilityAssessed after each exposure scenario (on the third day after 6 hours on defined train routes per day)

Heart rate variability is measured with the EndoPAT 2000 device during baseline recording. It includes time domain measures (SDNN, pNN50 and RMSSD), high (HF) and low frequency (LF) components as well as LF/HF ratio, based on measurements over 5 minutes.

Secondary Outcome Measures
NameTimeMethod
Serum/plasma bioactivityBlood is sampled, prepared and serum is stored after each exposure scenario (on the third day after 6 hours on defined train routes per day). Analysis is performed after sample collection completion.

To assess the potential effects on vascular and endothelial function \[14, 15\]

Systemic inflammatory markersBlood is sampled, prepared and stored after each exposure scenario (on the third day after 6 hours on defined train routes per day). Analysis is performed after sample collection completion.

Acute phase reactants, pro-inflammatory cytokines and cell adhesion molecules

Urinary excretion of 1-hydroxypyreneMorning urine is sampled, prepared and stored after each exposure scenario (on the morning of the third day after two days with 6 hours on defined train routes). Analysis is performed after sample collection completion.

The urinary biomarker of exposure to polycyclic aromatic hydrocarbons, 1-hydroxypyrene, is measured with reverse-phase HPLC and standardized for diuresis with the concentration of creatinine

Lung functionThe lung function is assessed after each exposure scenario (on the third day after 6 hours on defined train routes per day)

The lung function is measured with EasyOne 2001 spirometer device (Switzerland). Lung function measurements includes forced vital capacity (FVC), forced expiratory volume after 1 second (FEV1), peak expiratory flow (PEF) and FEV1/FVC.

Trial Locations

Locations (1)

University of Copenhagen

🇩🇰

Copenhagen, Denmark

© Copyright 2025. All Rights Reserved by MedPath